Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6950
+0.0250 (1.50%)
NASDAQ· Last Trade: Jun 4th, 12:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors